Healthstream (HSTM) Fundamental Analysis: Revenue, Earnings & Valuation

1.15 / 10

Underperform

Fundamental analysis rates HSTM as underperform with a 1.1/10 score, indicating weak quality. Interest coverage and asset‑MV are modest positives, while cash‑MV, quick ratio and liquidity metrics are bearish. Investors should remain prudent given the fragile fundamentals.

Analysis Checks(7/10)

Net assets per share (growth rate compared to beginning of year %)

Value1.36

Score2/3

Weight7.11%

1M Return-0.89%

Annualized return on equity (%)

Value5.14

Score2/3

Weight9.96%

1M Return-1.35%

Quick ratio

Value2.28

Score0/3

Weight23.75%

1M Return-3.43%

Fixed assets turnover ratio

Value11.24

Score1/3

Weight18.67%

1M Return-2.80%

Long-term debt to working capital ratio (%)

Value6.39

Score3/3

Weight-23.28%

1M Return3.06%

Interest coverage ratio (EBIT / Interest expense) (%)

Value35.11

Score2/3

Weight20.21%

1M Return-3.03%

Asset-MV

Value-0.49

Score2/3

Weight8.70%

1M Return-1.31%

ROE (%)

Value5.14

Score2/3

Weight9.96%

1M Return-1.35%

Current assets / Total assets (%)

Value22.99

Score3/3

Weight-11.46%

1M Return1.48%

Cash-MV

Value-0.63

Score0/3

Weight36.37%

1M Return-8.60%

Is HSTM fundamentally strong?

HSTM scores 1.15/10 on fundamentals and holds a Premium valuation at present. Backed by its 5.14% ROE, 6.03% net margin, 33.77 P/E ratio, 1.75 P/B ratio, and -7.58% earnings growth, these metrics solidify its Underperform investment rating.